ArticlePediatric nephrology (Berlin, Germany)2026

Obinutuzumab as a therapeutic option for SDNS children resistant to rituximab with anti-RTX antibodies.

Cyrielle Parmentier et al.PubMed ↗Publisher ↗

No numbers read from the abstract.